Showing results (41-50 of 220) with videos related to
Sort By:
Pageof 22
International MS Journal|January 20, 2006
MS treatment optimization: report from the 21st ETRIMS/10th ACTRIMS Congress, 28 September-1 October 2005, Thessaloniki, GreeceMichel Clanet, Reinhard HohlfeldNeurology|March 18, 2009
Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successesHeinz Wiendl, Reinhard HohlfeldBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 10, 2002
Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trialsHeinz Wiendl, Reinhard HohlfeldProceedings of the National Academy of Sciences of the United States of America|August 13, 2004
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelinesReinhard Hohlfeld, Hartmut WekerleInternational MS Journal|July 29, 2004
Neuroprotection in multiple sclerosis report from the MS Forum 16th Modern Management Workshop, March 2004, Cernobbio, ItalyReinhard Hohlfeld, Ludwig KapposBrain : a Journal of Neurology|November 11, 2005
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitmentMarkus Krumbholz, Diethilde Theil, Sabine Cepok, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 15, 2022
Antibody Therapies for Progressive Multiple Sclerosis and for Promoting RepairJoachim Havla, Reinhard HohlfeldNature Reviews. Neurology|October 2, 2009
Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosisTania Kümpfel, Reinhard HohlfeldJournal of Neuroimmunology|July 23, 2008
Reflections on the "intrathymic pathogenesis" of myasthenia gravisReinhard Hohlfeld, Hartmut WekerleJournal of Neuroinflammation|October 1, 2015
Fingolimod induces neuroprotective factors in human astrocytesFranziska S Hoffmann, Johann Hofereiter, Heike Rübsamen, et al.Pageof 22